Biocon Limited

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

Ask AI

Key metrics

Price as of 2026-07-20

Stock price
₹436.50
Market cap
70,757 Cr
Stock P/E
171.6
P/B
1.93
Dividend yield
0.1%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Sales3,423 Cr6,885 Cr10,839 Cr14,756 Cr3,433 Cr7,023 Cr3,821 Cr4,417 Cr3,942 Cr4,296 Cr4,173 Cr4,517 Cr
Operating expenses (approx.)2,615 Cr5,202 Cr7,642 Cr10,603 Cr1,646 Cr4,493 Cr3,052 Cr3,282 Cr3,113 Cr3,379 Cr3,633 Cr3,524 Cr
EBITDA808 Cr1,683 Cr3,197 Cr4,153 Cr1,787 Cr2,531 Cr770 Cr1,136 Cr829 Cr917 Cr540 Cr992 Cr
OPM %23.6%24.5%29.5%28.1%52.1%36.0%20.1%25.7%21.0%21.3%12.9%22.0%
Other income94 Cr251 Cr817 Cr866 Cr1,135 Cr1,137 Cr35 Cr37 Cr80 Cr93 Cr117 Cr53 Cr
Interest233 Cr481 Cr747 Cr974 Cr236 Cr462 Cr223 Cr212 Cr277 Cr272 Cr210 Cr232 Cr
Depreciation358 Cr747 Cr1,162 Cr1,569 Cr405 Cr825 Cr425 Cr436 Cr455 Cr473 Cr515 Cr513 Cr
Profit before tax217 Cr455 Cr1,288 Cr1,609 Cr1,146 Cr1,244 Cr156 Cr487 Cr97 Cr171 Cr-68 Cr248 Cr
Tax %16.0%16.8%10.2%14.1%24.8%28.5%48.0%5.6%7.9%22.5%23.6%19.8%
Net profit149 Cr322 Cr1,075 Cr1,298 Cr862 Cr889 Cr81 Cr459 Cr89 Cr133 Cr-52 Cr199 Cr
EPS (₹)₹0.85₹1.90₹7.42₹8.55₹5.51₹5.38₹0.21₹2.88₹0.26₹0.66₹1.08₹0.79

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales5,514 Cr6,367 Cr7,106 Cr8,184 Cr11,174 Cr14,756 Cr15,262 Cr16,927 CrSign in for TTM
Operating expenses (approx.)3,782 Cr4,535 Cr5,186 Cr6,112 Cr8,954 Cr11,469 Cr10,791 Cr13,532 CrSign in for TTM
EBITDA1,733 Cr1,832 Cr1,920 Cr2,072 Cr2,220 Cr3,287 Cr4,471 Cr3,395 CrSign in for TTM
OPM %31.4%28.8%27.0%25.3%19.9%22.3%29.3%20.1%Sign in for TTM
Other income144 Cr161 Cr255 Cr213 Cr376 Cr866 Cr1,208 Cr343 CrSign in for TTM
Interest71 Cr65 Cr58 Cr68 Cr419 Cr974 Cr897 Cr990 CrSign in for TTM
Depreciation448 Cr552 Cr715 Cr814 Cr1,113 Cr1,569 Cr1,687 Cr1,957 CrSign in for TTM
Profit before tax1,214 Cr1,215 Cr1,147 Cr1,190 Cr1,064 Cr1,609 Cr1,887 Cr448 CrSign in for TTM
Tax %17.5%25.9%19.3%17.8%23.9%14.1%24.2%17.7%Sign in for TTM
Net profit1,003 Cr871 Cr846 Cr772 Cr643 Cr1,298 Cr1,429 Cr369 CrSign in for TTM
EPS (₹)₹15.30₹6.32₹6.24₹5.44₹3.88₹8.55₹8.46₹2.82Sign in for TTM
Dividend payout %———-44.9%11.2%15.6%5.8%24.6%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital300 Cr600 Cr600 Cr600 Cr600 Cr600 Cr600 Cr811 Cr
Reserves5,798 Cr6,106 Cr7,026 Cr7,832 Cr17,267 Cr19,183 Cr27,112 Cr33,221 Cr
Borrowings————17,771 Cr15,730 Cr5,350 Cr4,078 Cr
Other liabilities6,094 Cr7,738 Cr10,896 Cr11,962 Cr11,783 Cr15,066 Cr25,735 Cr22,951 Cr
Total liabilities12,192 Cr14,444 Cr18,522 Cr20,394 Cr52,043 Cr56,071 Cr58,797 Cr63,651 Cr
Fixed assets (net)————7,535 Cr7,418 Cr8,708 Cr9,473 Cr
CWIP————2,588 Cr3,985 Cr4,102 Cr4,613 Cr
Investments————1,931 Cr1,000 Cr1,127 Cr1,779 Cr
Other assets————12,334 Cr15,179 Cr16,286 Cr17,180 Cr
Total assets12,192 Cr14,444 Cr18,522 Cr20,394 Cr52,043 Cr56,071 Cr58,797 Cr63,651 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity———1,177 Cr1,853 Cr2,954 Cr4,061 Cr1,994 Cr
Cash from investing———-1,699 Cr-14,282 Cr-1,004 Cr-234 Cr-2,082 Cr
Cash from financing———242 Cr13,049 Cr-2,333 Cr-1,854 Cr-924 Cr
Net cash flow———-277 Cr641 Cr-380 Cr2,004 Cr-812 Cr
Free cash flow (OCF − Capex)———-521 Cr257 Cr1,273 Cr1,925 Cr196 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %21.1%19.1%15.8%14.9%2.8%4.2%8.4%3.5%
ROE %14.8%11.2%9.7%7.7%2.1%4.0%3.7%1.1%
Debtor days————116154——
Inventory days————484356420420
Days payable————454451——
Cash conversion cycle————14659420420
Debt / equity————0.990.800.190.11
Current ratio————1.450.991.141.22
Net debt / EBITDA0.000.000.000.007.414.410.470.49

Compare with peers

Loading peers…